Silence Therapeutics (SLN) Shares Outstanding (Diluted) (2022 - 2026)

Silence Therapeutics (SLN) Shares Outstanding (Diluted) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 255.20 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 106.00 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 64.41 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 210.89 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.51 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 25.05 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 556.90 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 138.28 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 217.35 Mn
10 Silence Therapeutics 648.22 Mn 576.12 Mn - 141.71 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 141.71 Mn
Mar 31, 2026 141.70 Mn
Dec 31, 2025 141.69 Mn
Sep 30, 2025 141.70 Mn
Jun 30, 2025 141.70 Mn
Mar 31, 2025 141.68 Mn
Dec 31, 2024 138.75 Mn
Sep 30, 2024 141.20 Mn
Jun 30, 2024 140.21 Mn
Mar 31, 2024 131.88 Mn
Dec 31, 2023 111.28 Mn
Dec 31, 2022 96.58 Mn